These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22986785)

  • 21. Anti-Inflammatory Activity of Dehydroandrographolide by TLR4/NF-κB Signaling Pathway Inhibition in Bile Duct-Ligated Mice.
    Weng Z; Chi Y; Xie J; Liu X; Hu J; Yang F; Li L
    Cell Physiol Biochem; 2018; 49(3):1083-1096. PubMed ID: 30196285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p21 ablation in liver enhances DNA damage, cholestasis, and carcinogenesis.
    Ehedego H; Boekschoten MV; Hu W; Doler C; Haybaeck J; Gaβler N; Müller M; Liedtke C; Trautwein C
    Cancer Res; 2015 Mar; 75(6):1144-55. PubMed ID: 25608711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH.
    Ramadori P; Drescher H; Erschfeld S; Fragoulis A; Kensler TW; Wruck CJ; Cubero FJ; Trautwein C; Streetz KL; Kroy DC
    Oxid Med Cell Longev; 2017; 2017():3420286. PubMed ID: 28676836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation.
    Nozaki I; Lunz JG; Specht S; Stolz DB; Taguchi K; Subbotin VM; Murase N; Demetris AJ
    Lab Invest; 2005 Jan; 85(1):109-23. PubMed ID: 15558059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns.
    Juanola O; Hassan M; Kumar P; Yilmaz B; Keller I; Simillion C; Engelmann C; Tacke F; Dufour JF; De Gottardi A; Moghadamrad S
    Gut Microbes; 2021; 13(1):1-20. PubMed ID: 33847205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Phospho-c-Jun N-Terminal Kinase Expression on hepatocyte Necrosis and Autophagy in the Cholestatic Liver.
    Kwak BJ; Choi HJ; Kim OH; Kim KH; You YK; Lee TY; Ahn J; Kim SJ
    J Surg Res; 2019 Sep; 241():254-263. PubMed ID: 31035140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.
    Ezure T; Sakamoto T; Tsuji H; Lunz JG; Murase N; Fung JJ; Demetris AJ
    Am J Pathol; 2000 May; 156(5):1627-39. PubMed ID: 10793074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
    Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
    Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats.
    Zhu H; Chai Y; Dong D; Zhang N; Liu W; Ma T; Wu R; Lv Y; Hu L
    Can J Gastroenterol Hepatol; 2018; 2018():6181432. PubMed ID: 30662889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caspase 8 differentially controls hepatocytes and non-parenchymal liver cells during chronic cholestatic liver injury in mice.
    Chaudhary K; Liedtke C; Wertenbruch S; Trautwein C; Streetz KL
    J Hepatol; 2013 Dec; 59(6):1292-8. PubMed ID: 23928400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo.
    Pietrangelo A; Dierssen U; Valli L; Garuti C; Rump A; Corradini E; Ernst M; Klein C; Trautwein C
    Gastroenterology; 2007 Jan; 132(1):294-300. PubMed ID: 17241879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
    Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
    Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.
    Sander LE; Sackett SD; Dierssen U; Beraza N; Linke RP; Müller M; Blander JM; Tacke F; Trautwein C
    J Exp Med; 2010 Jul; 207(7):1453-64. PubMed ID: 20530204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse.
    Kahraman A; Barreyro FJ; Bronk SF; Werneburg NW; Mott JL; Akazawa Y; Masuoka HC; Howe CL; Gores GJ
    Hepatology; 2008 Apr; 47(4):1317-30. PubMed ID: 18220275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepcidin protects against lipopolysaccharide-induced liver injury in a mouse model of obstructive jaundice.
    Huang YH; Yang YL; Tiao MM; Kuo HC; Huang LT; Chuang JH
    Peptides; 2012 Jun; 35(2):212-7. PubMed ID: 22504010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
    Gong Z; Zhou J; Zhao S; Tian C; Wang P; Xu C; Chen Y; Cai W; Wu J
    Oncotarget; 2016 Dec; 7(51):83951-83963. PubMed ID: 27924062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis.
    Beraza N; Ofner-Ziegenfuss L; Ehedego H; Boekschoten M; Bischoff SC; Mueller M; Trauner M; Trautwein C
    Gut; 2011 Mar; 60(3):387-96. PubMed ID: 21115542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma.
    Cubero FJ; Mohamed MR; Woitok MM; Zhao G; Hatting M; Nevzorova YA; Chen C; Haybaeck J; de Bruin A; Avila MA; Boekschoten MV; Davis RJ; Trautwein C
    Hepatol Commun; 2020 Jun; 4(6):834-851. PubMed ID: 32490320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice.
    Fiorotto R; Scirpo R; Trauner M; Fabris L; Hoque R; Spirli C; Strazzabosco M
    Gastroenterology; 2011 Oct; 141(4):1498-508, 1508.e1-5. PubMed ID: 21712022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
    Takemura T; Yoshida Y; Kiso S; Kizu T; Furuta K; Ezaki H; Hamano M; Egawa M; Chatani N; Kamada Y; Imai Y; Higashiyama S; Iwamoto R; Mekada E; Takehara T
    Biochem Biophys Res Commun; 2013 Jul; 437(2):185-91. PubMed ID: 23743191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.